Literature DB >> 18985386

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Nathan Pankratz1, Jemma B Wilk, Jeanne C Latourelle, Anita L DeStefano, Cheryl Halter, Elizabeth W Pugh, Kimberly F Doheny, James F Gusella, William C Nichols, Tatiana Foroud, Richard H Myers.   

Abstract

Five genes have been identified that contribute to Mendelian forms of Parkinson disease (PD); however, mutations have been found in fewer than 5% of patients, suggesting that additional genes contribute to disease risk. Unlike previous studies that focused primarily on sporadic PD, we have performed the first genomewide association study (GWAS) in familial PD. Genotyping was performed with the Illumina HumanCNV370Duo array in 857 familial PD cases and 867 controls. A logistic model was employed to test for association under additive and recessive modes of inheritance after adjusting for gender and age. No result met genomewide significance based on a conservative Bonferroni correction. The strongest association result was with SNPs in the GAK/DGKQ region on chromosome 4 (additive model: p = 3.4 x 10(-6); OR = 1.69). Consistent evidence of association was also observed to the chromosomal regions containing SNCA (additive model: p = 5.5 x 10(-5); OR = 1.35) and MAPT (recessive model: p = 2.0 x 10(-5); OR = 0.56). Both of these genes have been implicated previously in PD susceptibility; however, neither was identified in previous GWAS studies of PD. Meta-analysis was performed using data from a previous case-control GWAS, and yielded improved p values for several regions, including GAK/DGKQ (additive model: p = 2.5 x 10(-7)) and the MAPT region (recessive model: p = 9.8 x 10(-6); additive model: p = 4.8 x 10(-5)). These data suggest the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and also provide further support for the role of SNCA and MAPT in PD susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985386      PMCID: PMC2627511          DOI: 10.1007/s00439-008-0582-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Considerations for genomewide association studies in Parkinson disease.

Authors:  Richard H Myers
Journal:  Am J Hum Genet       Date:  2006-06       Impact factor: 11.025

Review 2.  Whole-genome genotyping.

Authors:  Kevin L Gunderson; Frank J Steemers; Hongi Ren; Pauline Ng; Lixin Zhou; Chan Tsan; Weihua Chang; Dave Bullis; Joe Musmacker; Christine King; Lori L Lebruska; David Barker; Arnold Oliphant; Kenneth M Kuhn; Richard Shen
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Genetic model testing and statistical power in population-based association studies of quantitative traits.

Authors:  Guillaume Lettre; Christoph Lange; Joel N Hirschhorn
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

Review 4.  Parkinson's disease and family history.

Authors:  Annabella N Sellbach; Richard S Boyle; Peter A Silburn; George D Mellick
Journal:  Parkinsonism Relat Disord       Date:  2006-06-22       Impact factor: 4.891

5.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

6.  Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.

Authors:  Nathan Pankratz; Michael W Pauciulo; Veronika E Elsaesser; Diane K Marek; Cheryl A Halter; Alice Rudolph; Clifford W Shults; Tatiana Foroud; William C Nichols
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data.

Authors:  Hon-Chung Fung; Sonja Scholz; Mar Matarin; Javier Simón-Sánchez; Dena Hernandez; Angela Britton; J Raphael Gibbs; Carl Langefeld; Matt L Stiegert; Jennifer Schymick; Michael S Okun; Ronald J Mandel; Hubert H Fernandez; Kelly D Foote; Ramón L Rodríguez; Elizabeth Peckham; Fabienne Wavrant De Vrieze; Katrina Gwinn-Hardy; John A Hardy; Andrew Singleton
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

8.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

Authors:  Mei Sun; Jeanne C Latourelle; G Frederick Wooten; Mark F Lew; Christine Klein; Holly A Shill; Lawrence I Golbe; Margery H Mark; Brad A Racette; Joel S Perlmutter; Abbas Parsian; Mark Guttman; Garth Nicholson; Gang Xu; Jemma B Wilk; Marie H Saint-Hilaire; Anita L DeStefano; Ranjana Prakash; Sally Williamson; Oksana Suchowersky; Nancy Labelle; John H Growdon; Carlos Singer; Ray L Watts; Stefano Goldwurm; Gianni Pezzoli; Kenneth B Baker; Peter P Pramstaller; David J Burn; Patrick F Chinnery; Scott Sherman; Peter Vieregge; Irene Litvan; Tammy Gillis; Marcy E MacDonald; Richard H Myers; James F Gusella
Journal:  Arch Neurol       Date:  2006-06

9.  Tau gene and Parkinson's disease: a case-control study and meta-analysis.

Authors:  D G Healy; P M Abou-Sleiman; A J Lees; J P Casas; N Quinn; K Bhatia; A D Hingorani; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

10.  Planning genetic studies on primary adult-onset dystonia: sample size estimates based on examination of first-degree relatives.

Authors:  Giovanni Defazio; Davide Martino; Maria Stella Aniello; Gianluca Masi; Angelo Gigante; Kailash Bhatia; Paolo Livrea; Alfredo Berardelli
Journal:  J Neurol Sci       Date:  2006-10-31       Impact factor: 3.181

View more
  218 in total

1.  SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.

Authors:  Ignacio F Mata; Min Shi; Pinky Agarwal; Kathryn A Chung; Karen L Edwards; Stewart A Factor; Douglas R Galasko; Carmen Ginghina; Alida Griffith; Donald S Higgins; Denise M Kay; Hojoong Kim; James B Leverenz; Joseph F Quinn; John W Roberts; Ali Samii; Katherine W Snapinn; Debby W Tsuang; Dora Yearout; Jing Zhang; Haydeh Payami; Cyrus P Zabetian
Journal:  Arch Neurol       Date:  2010-11

2.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

3.  Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.

Authors:  Xiao-Xia Li; Qin Liao; Huan Xia; Xin-Ling Yang
Journal:  Exp Ther Med       Date:  2015-07-27       Impact factor: 2.447

4.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

Review 5.  The genetics of Parkinson's disease: progress and therapeutic implications.

Authors:  Andrew B Singleton; Matthew J Farrer; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2013-01       Impact factor: 10.338

6.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Authors:  Colton Linnertz; Michael W Lutz; John F Ervin; Jawara Allen; Natalie R Miller; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

7.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

8.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

9.  A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease.

Authors:  Madeleine Kristiansen; Jodi Maple-Grødem; Guido Alves; Sampath Arepalli; Dena G Hernandez; Hirotaka Iwaki; Mike A Nalls; Andrew Singleton; Ole-Bjørn Tysnes; Mathias Toft; Lasse Pihlstrøm
Journal:  Mov Disord       Date:  2018-11-28       Impact factor: 10.338

Review 10.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.